AYALA PHARMACEUTICALS INC
COM · CUSIP 05465V108
1
institutional holders
-11 vs Q4 2022
$0reported value*
0 new
0 added
0 reduced
11 sold out
net sold ≈ $946.5k (-2.4m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 15 |
| Q4 2022 | 12 |
| Q1 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 4 | 10 |
| Q1 2023 | 0 | 11 |
Biggest buyers
| None |
Biggest sellers
| Harel Insurance Investments & Financial Services Ltd. | Sold out | -2.2m |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Sold out | -56.9k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -53.6k |
| Psagot Value Holdings Ltd. / (Israel) | Sold out | -36.2k |
| TWO SIGMA SECURITIES, LLC | Sold out | -16.1k |
| MORGAN STANLEY | Sold out | -13.9k |
| CITADEL ADVISORS LLC | Sold out | -11.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -10.6k |
| Avantax Planning Partners, Inc. | Sold out | -10.0k |
| UBS Group AG | Sold out | -1.0k |
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |